FDA
-
-
-
-
-
-
-
Tango Therapeutics names Matthew Gall CFO, adds two executives
-
-
-
-
-
-
-
Tango Therapeutics Appoints Sung Lee to Board of Directors
-
-
-
-
-
-
-
Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
-
-
-
-
-
-
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business HighlightsÂ
-
-
-
-
-
-
-
Tango Therapeutics, Inc (TNGX) Announces FDA Clearance of Investigational New Drug Application for TNG348
-
-
-
-
-
-
-
Tango Therapeutics, Inc (TNGX) Announces FDA Clearance of Investigational New Drug Application for TNG260
-
-
-
-
-
-
-
Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights
-
334,870 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


